Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mouse nerve growth factor for children with spastic diplegic cerebral palsy
ChiCTR2000032880Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Jiamusi University
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of mouse nerve growth factor in cerebral palsy (CP) (2 arms), sponsored by The Third Affiliated Hospital of Jiamusi University. Primary endpoint: Gross Motor Function Measure-88. Planned start May 2020; status: not yet recruiting.
02
Drugs
mouse nerve growth factor
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on ChiCTR2000032880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032880.